by Eric Christianson | Apr 19, 2026 | Respiratory Medication and Disease State Clinical Pearls
Beta-blockers have long been approached with caution in patients with asthma due to their potential to provoke bronchospasm and blunt the effects of rescue inhalers. This risk is largely driven by receptor selectivity. In this article, we will break down the best and...
by Eric Christianson | Jan 25, 2026 | Respiratory Case Studies
In this case study, we outline a likely case of propranolol-induced asthma. Mr. J.S. is a 62-year-old male with a past medical history significant for essential tremor, mild persistent asthma, hypertension, and hyperlipidemia. His asthma has been well controlled for...
by Eric Christianson | Jul 16, 2025 | Polypharmacy Cases And The Prescribing Cascade
Counteracting drug effects are all too common in geriatric and polypharmacy patients. I wanted to share common examples that I’ve seen in my practice as a clinical pharmacist. NSAIDs vs. AntihypertensivesCase: A 68-year-old man with hypertension controlled on...
by Eric Christianson | May 29, 2019 | Drug Interaction Case Studies and Education For Pharmacists
The albuterol beta-blocker interaction is real and is significant. But how significant is it? What questions should you ask yourself? Which Beta-Blocker We Talkin’ Bout? The very first question I would assess is which beta-blocker are we talking about as not all...
